Literature DB >> 29188854

Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial.

A F Cicero1, M Bove, A Colletti, M Rizzo, F Fogacci, M Giovannini, C Borghi.   

Abstract

BACKGROUND: The prevalence of senile dementia is increasing worldwide, especially in the developed countries. Nevertheless, drug therapy isn't often enough to treat this condition. Researchers are evaluating the possible impact of a preventive approach, based on an improvement of lifestyle and the intake of micronutrients. Moreover, there is an increasing interest for combined nutraceuticals that can act as memory and learning enhancers, with a significant and beneficial potential on the cognitive disorders.
OBJECTIVE: To evaluate the effects of a rational assemblage of nutraceuticals on cognitive functions in a sample of 30 elderly subjects.
DESIGN: Double bind, cross-over designed trial versus placebo Setting: outpatient clinical practice. PARTICIPANTS: 30 elderly subjects with basal Mini-Mental State Examination score between 20 and 27 and self-perceived cognitive decline. INTERVENTION: Treatment with a combination of nutraceuticals based on Bacopa monnieri, L-theanine, Crocus sativus, copper, folate and vitamins of B and D group. After2 months of treatment or placebo. MEASUREMENTS: Patients were evaluated with Mini-Mental State Examination (MMSE), Perceived Stress Questionnaire (PSQ) and Index and Self-Rating Depression Scale (SRDS).
RESULTS: MMSE and PSQ Index significantly improved in the active treatment arm, both versus baseline and versus the parallel arm. Both groups experienced a significant improving in the SRDS scores.
CONCLUSIONS: We obtained a good and significant improvement of the cognitive functions tested with the MMSE, PSQ-Index and SRDS score, after 2 months of combined therapy of nutraceuticals. Further confirmation will be needed to verify these observations on the middle and long term in a larger number of subjects.

Entities:  

Keywords:  Clinical trialzzm321990; cognitive impairment; depression; dietary supplement; elderly

Mesh:

Year:  2017        PMID: 29188854     DOI: 10.14283/jpad.2016.10

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  6 in total

Review 1.  Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies.

Authors:  Aimi Syamima Abdul Manap; Shantini Vijayabalan; Priya Madhavan; Yoke Yin Chia; Aditya Arya; Eng Hwa Wong; Farzana Rizwan; Umesh Bindal; Shajan Koshy
Journal:  Drug Target Insights       Date:  2019-07-31

Review 2.  Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge.

Authors:  Marco Di Paolo; Luigi Papi; Federica Gori; Emanuela Turillazzi
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

3.  The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data.

Authors:  James M Brimson; Sirikalaya Brimson; Mani Iyer Prasanth; Premrutai Thitilertdecha; Dicson Sheeja Malar; Tewin Tencomnao
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection.

Authors:  Marilisa Bove; Federica Fogacci; Silvia Quattrocchi; Maddalena Veronesi; Arrigo F G Cicero
Journal:  Arch Med Sci       Date:  2021-09-17       Impact factor: 3.318

Review 5.  Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials.

Authors:  Aneesh Basheer; Ayush Agarwal; Biswamohan Mishra; Anu Gupta; Madakasira Vasantha Padma Srivastava; Richard Kirubakaran; Venugopalan Vishnu
Journal:  Interact J Med Res       Date:  2022-08-01

Review 6.  Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence.

Authors:  Seyedeh Farzaneh Omidkhoda; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2022-08       Impact factor: 2.532

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.